Brett Kaplan - Feb 18, 2022 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Director
Signature
/s/ Vered Bisker-Leib, attorney-in-fact
Stock symbol
CMPX
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 04:45 PM
Next filing
Aug 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +30K $0.00 30K Feb 18, 2022 Common Stock 30K $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in substantially equal monthly installments over four years.